This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis of gastric cancer

Authoring team

TThe 5-year survival rate for curative surgical resection ranges from:

  • 30-50% for patients with stage II disease
  • from 10-25% for patients with stage III disease
  • for all cases referred, the overall 5-year survival is approximately 20%
  • 44% of men survive stomach cancer for at least one year, and this is predicted to fall to 20% surviving for five years or more
  • survival for women is slightly lower at one year but similar at five years, with 38% surviving for one year or more, and 18% predicted to survive for at least five years.

 

Early gastric cancer (EGC) has been defined as a gastric carcinoma confined to the mucosa and/or submucosa, regardless of the size or presence of lymph node metastasis

  • EGCs have a low incidence of lymph node metastasis and a favorable outcome after surgery
  • patients with EGC generally have an excellent prognosis after curative resection (R0), with 5- and 10-year survival rates of more than 90% and 85-90%, respectively

 

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.